Equity Overview
Price & Market Data
Price: $4.89
Daily Change: +$0.41 / 8.38%
Range: $4.32 - $5.11
Market Cap: $175,026,816
Volume: 126,568
Performance Metrics
1 Week: 76.20%
1 Month: 2.07%
3 Months: -15.74%
6 Months: -21.83%
1 Year: -21.83%
YTD: -10.00%
Company Details
Employees: 136
Sector: Health technology
Industry: Medical specialties
Country: Australia
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.